Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Johnson & Johnson in Podcasts

company

Johnson & Johnson, multinational pharmaceutical and consumer goods company

company consumer goods consumer_goods health healthcare medical_devices opioids pharma pharmaceutical pharmaceuticals controversial (0.800000011920929)

Mentions Over Time

10 mentions
1 related entities

Related Entities

Johnson & Johnson

employed_by

Mentions in Podcasts

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

They give a priority voucher to Johnson & Johnson's Majestic 3 trial, which showed an enormous overall survival benefit over already a great success with CAR T's in multiple myeloma.

WSJ What’s News
President Trump’s Sudden U-Turn on Greenland

While Johnson & Johnson reported higher revenue and profit for the latest quarter, with a boost from higher sales of drugs that treat cancer and autoimmune conditions.

Wall Street Breakfast
Trump backs off Greenland tariffs

Johnson & Johnson reported better than expected Q4 revenue, driven by its pharma and medtech divisions, but adjusted earnings for the quarter missed expectations.

Vanguards of Health Care by Bloomberg Intelligence
Merck’s GHI Fund and the Push to Rewire Pharma's Future

He previously spent 18 years at Johnson & Johnson, including time in its venture arm, the J&J Development Corp.

The Daily Show: Ears Edition
TDS Time Machine | Big Pharma

Yesterday, an Oklahoma judge ruled that opioids ravaged the state and ordered Johnson & Johnson to pay $572 million.

Wall Street Breakfast
IBM to buy Confluent in further AI push

Pfizer, Bristol-Myers Squibb, and Johnson & Johnson contributed cancer drugs to the catalog.

NPR News Now
NPR News: 12-24-2025 4AM EST

A jury has awarded Johnson & Johnson, ordered Johnson & Johnson and its subsidiaries to pay $1.5 billion to a Baltimore woman after finding the company liable for exposing her to asbestos through baby powder.